Clinical Trial Update: Subcutaneous Bupivacaine Decrease Post-op Pain in Patients Undergoing C-Section [Phase 2]

View source ↗

Summary

Phase 2 trial assessing subcutaneous bupivacaine to reduce postoperative pain in cesarean section patients; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Section Pain
• Postoperative Pain

Drugs mentioned

• Bupivacaine (Bupivacaine)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Pain, Referred | Phase 2 | Status: TERMINATED | Results posted: 2020-01-13